Anúncio
Anúncio
FLGT
Fulgent Genetics, Inc. Common Stock
27.86
USDPatrocinado
-0.03
-0.09%
09 de jan., 15:58 UTC -5
Encerrado
Pós-Mercado
27.71
-0.15
-0.54%
Relatórios de Lucros FLGT
Rácio de surpresa positiva
FLGT separação 28 de 37 últimas estimativas.
76%
Próximo Relatório
Data do Próximo Relatório
26 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$87.09M
/$0.03
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+3.59%
/-78.57%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+14.27%
/-25.00%
Fulgent Genetics, Inc. Common Stock earnings per share and revenue
On 07 de nov. de 2025, FLGT reported earnings of 0.14 USD per share (EPS) for Q3 25, beating the estimate of -0.22 USD, resulting in a 161.46% surprise. Revenue reached 84.07 milhão, compared to an expected 83.06 milhão, with a 1.22% difference. The market reacted with a +18.15% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of 0.03 USD, with revenue projected to reach 87.09 milhão USD, implying an diminuir of -78.57% EPS, and aumentar of 3.59% in Revenue from the last quarter.
FAQ
What were Fulgent Genetics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Fulgent Genetics, Inc. Common Stock reported EPS of $0.14, beating estimates by 161.46%, and revenue of $84.07M, 1.22% above expectations.
How did the market react to Fulgent Genetics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 18.15%, changed from $22.31 before the earnings release to $26.36 the day after.
When is Fulgent Genetics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 26 de fev. de 2026.
What are the forecasts for Fulgent Genetics, Inc. Common Stock's next earnings report?
Based on 5
analistas, Fulgent Genetics, Inc. Common Stock is expected to report EPS of $0.03 and revenue of $87.09M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio